Renalyx Launches World's First Indigenous AI based Smart Hemodialysis Machine, Makes Renal Care Accessible and Affordable
Completely designed and manufactured in India, RENALYX – RxT 21 leverages latest technologies including cloud-based telenephrology platforms to offer safety and quality care to kidney patients, end-stage renal disease (ESRD) patients especially those with cardiovascular, pulmonary and acute kidney injury-related issues.
RENALYX – RxT 21 makes Renalyx the sixth company globally and first in India to produce an advanced dialysis machine with EU CE certification.
Renalyx has plans to invest INR 800 crores in the next four years to build the manufacturing capacity of 5,000 machines by FY25-26 and will develop additional capacity of 1500 machines by FY27-28. The company also have plans to manufacture consumables indigenously. The company has manufacturing facilities at Bengaluru and Mysuru in Karnataka and at Mumbai in Maharashtra to support its scale-up plans and meet the growing demand.
The company plans to raise funds through the sale of equity, backed by strong interest from prominent Indian and international investors. In addition, it will raise debt, and the promoters will also invest capital. Renalyx also has plans to go public within the next three years.
With initial deployments of the machine planned in Maharashtra and Karnataka, Renalyx will go for rapid pan-India distribution of RENALYX – RxT 21 with its partners as well as exports to other countries. The company has successfully penetrated international markets, securing orders from South Africa, the USA, and Europe.
Commenting on the launch of Rx T21, Dr. Shyam Vasudeva Rao, Founder & Director of Renalyx Health Systems said, 'Our cutting-edge hemodialysis machine will revolutionise the renal care by making dialysis facility affordable and accessible, thus strengthening the kidney healthcare infrastructure of the country. By bringing dialysis services closer to patients' homes, RxT 21 will help in addressing the rising Chronic Kidney Disease (CKD) burden and ESRD patients. Our indigenously developed hemodialysis machine will play a game-changing role in reducing dialysis expense, thus ensuring better healthcare impact. Going forward, we have plans to scale up our manufacturing capacity and reduce the Total Cost of Ownership of RxT 21 by 40% compared to that of imported machines. We have plans to develop a broader range of technologically advanced machines over the next three years, including a home dialysis model. In line with the government vision of 'Make in India Make for the World', we aim to export our machine to various countries to make a larger impact on renal care infrastructure globally. We aim to become one of the world's leading producers and exporters within the next five years.'
The Indian CDSCO approval of the machine is in its final stages and is expected by July 2025, while the U.S. FDA approval process is underway and anticipated by March 2026.
The RENALYX – RxT 21 machines are equipped with advanced features such as Integrated Nephrology Information System (NIS) on the cloud, AI based smart algorithms, Electronic Medical Records (EMR) integration, remote diagnostics and alerts through real-time telemetry, Advanced image processing, Internet of Medical Things (IoMT) capabilities for continuous performance monitoring and clinical oversight. Thanks to these advanced features, doctors can remotely access patients' EMR, current settings of the dialysis machine and patients' critical event history to take action and advise necessary treatment and care.
Renalyx plans to install RxT 21 at primary health centres (PHC), community health centres (CHC), private dialysis centres and hospitals to make renal care available to a large number of people. The company has set up local service teams and created technician training programs to ensure smooth roll-out of the smart machines. The company will set up franchisee centres across India along with its partners
The company, in collaboration with its partner, will set up franchise centres across India and in international markets.
In addition, Renalyx has awarded a manufacturing license to Bharat Electronics Ltd. (BEL) to produce 6,000 RENALYX – RxT 17 in the next three years. RENALYX – RxT 17 is a previously launched dialysis machine by Renalyx which comes with standard features and facilities. With RENALYX – RxT 21 and RxT 17, Renalyx aims to play its role in making dialysis services affordable and accessible to the rural areas due to the recurring nature of the treatment. According to Pradhan Mantri National Dialysis Program (PMNDP) data, approximately 2.2 lakh new cases of End-Stage Renal Disease (ESRD) are reported in India each year, creating an additional demand for 3.4 crore dialysis sessions annually.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
28 minutes ago
- Hindustan Times
Yashobhoomi convention centre in Delhi's Dwarka wins International Architecture Award 2024
New Delhi It was inaugurated in September 2023 by Prime Minister Narendra Modi. (HT Archive) The Yashobhoomi Convention and Exhibition Centre in Dwarka, southwest Delhi, has won the International Architecture Award 2024 under the 'Civic Centre' category, which will be presented next month at the historic Acropolis in Athens, Greece, a globally recognised landmark in architecture. The prize is awarded by The Chicago Athenaeum: Museum of Architecture and Design, and The European Centre for Architecture Art, Design and Urban Studies. Dikshu C Kukreja, managing principal of CP Kukreja Architects, which designed the centre, said: 'Yashobhoomi embodies Prime Minister Narendra Modi's vision of positioning India as a leading global hub.' Designed in collaboration with IDOM (Spain), Yashobhoomi spans 225 acres and has a built-up area of 2.2 million square feet. It was inaugurated in September 2023 by Prime Minister Narendra Modi. The venue, built at a cost of ₹5,400 crore, features multiple exhibition halls, auditoriums and conference rooms to host trade and diplomatic events. Kukreja said the Union ministry of commerce selected them for the global competition. The firm is renowned for designing the Jawaharlal Nehru University and the Ambadeep Towers in Delhi. It was recently internationally recognised for designing the Madhya Pradesh state secretariat and Gautam Buddha University. Recalling that the project's conceptualisation involved close collaboration with retired IAS officer Amitabh Kant, who was also the G20 Sherpa, to ensure the facility could host high-profile gatherings, such as the G20 Summit. After the award was announced, Kant thanked the Prime Minister on the social media platform X, 'for the vision and opportunity to conceptualise and drive it as Secretary DIPP (Department of Industrial Policy & Promotion)'. What sets Yashobhoomi apart, Kukreja said, is its fusion of modern technology with traditional Indian identity. 'It's easy to copy global examples from Germany, Korea, or the US; but for me, it was essential to root the design in India's ethos—through stepwell-inspired forms, jali screens, aangan-like light courts, and interiors steeped in Indian art and motifs.' He said the exhibition hall spans an area equivalent to four football fields. The venue features a 100-metre column-free span and the world's largest LED facade. 'The venue is also India's first to incorporate retractable seating that can transform a 6,000-seater hall into a flat-floored multi-purpose space at the touch of a button,' he said. Large venues like this often turn into 'white elephants' due to a lack of versatility. 'So, we ensured that the hall can have multiple uses,' he said. Kukreja said sustainability was a core design priority, and this secured the Indian Green Building Council's platinum rating. 'Steel was chosen to minimise localised pollution. This ensured durability and lower carbon impact, while featuring recycled materials, locally sourced granite and marble, and off-site fabricated glass-reinforced concrete,' he said. Kukreja said the award was more than personal recognition. 'This is about India creating architecture the world talks about and respects.'
Time of India
43 minutes ago
- Time of India
The MarTech Makeover of U-Sell and X-Sell
Dear Reader, Once upon a time, cross-selling belonged squarely in the domain of sales. It was defined by a handshake, a smile, and the classic prompt, 'Will you have fries with that?' Today, it's moved into marketing's territory, powered by data, automated campaigns, and connected brand ecosystems. What used to happen at the counter now happens in your inbox, your app, and even your social media feed. This week, we unpack how that shift happened, and how marketers have brought a whole new dimension to cross selling and upselling . Plus, we dive into APIs powering the modern digital landscape and explore how AI has already become your customers' shopping companion. Let's jump in. Will you have fries with that? Cross-selling and upselling used to be all about face-to-face persuasion. Now, it's in the hands of marketers using behavioural data, Martech stacks, and cross-channel journeys. Read more Why you should care: Because marketing isn't just about the first sale anymore, it's about nudging the next one, and the next. Mastering this = more revenue, better CX. APIs: The MarTech Glossary APIs might sound technical, but they're the invisible glue holding together the modern Martech stack, powering everything from CRMs to chatbots. Read more Why you should care: Because if you're stitching together tools (and who isn't?), API literacy can save time, reduce friction, and keep your data flowing seamlessly. AI is now the consumer's 'good friend' A staggering 95% of Indian consumers use AI to make purchase decisions, finds an Accenture report. And over half of active users consider AI a 'good friend'. Read more Why you should care: Because marketing to a consumer who's already consulting AI means your strategy must evolve, from influencing people to influencing their algorithms. Over to you How is your team using data to upsell smarter? Or APIs to make your stack sing? Tell us what you're experimenting with, tag @ETBrandEquity on LinkedIn and let's swap notes. Stay tuned for the next edition of the MarTech+ newsletter rolling out every week on Wednesday. – Team ETBrandEquity
Business Standard
an hour ago
- Business Standard
Qure.ai Hosts High-Impact Policy Roundtable at Constitution Club of India to Champion AI in Public Health
VMPL New Delhi [India], August 13: a leading Indian deep-tech company and global healthcare AI pioneer, hosted a high-level roundtable on August 6 at the Constitution Club of India. The event brought together Members of Parliament, senior bureaucrats, public health leaders, and international development experts to discuss the role of artificial intelligence in strengthening India's public healthcare systems. The roundtable focused on bringing to light the diverse challenges faced by India's public health system, as voiced by policymakers from across the country. Members of Parliament representing rural and underserved constituencies highlighted gaps in early diagnosis, overburdened health workers, and limited infrastructure--issues that could be effectively addressed through AI-enabled tools. By grounding the conversation in real, on-the-ground realities, the event demonstrated how healthcare AI, when responsibly integrated, could serve as a practical solution to systemic problems. The gathering brought together prominent figures, including Members of Parliament Shri K. Francis George (Kottayam, Kerala), Shri Chatrapati Shahu Maharaj (Kolhapur, Maharashtra), and Shri Darshan Singh Chaudhary (Hoshangabad, Madhya Pradesh), as well as Shri Sudhaker Singh, former Agriculture Minister of Buxar, Bihar. Leaders from the global development sector--such as Mr. Harish Iyer (Gates Foundation), Dr. Jacob Creswell (Stop TB Partnership), Dr. Preet Deep Singh (APNA and Startup India), and Mr. Savio Rodrigues (founder, GoaChronicle)--also contributed to the discussion. Key points raised during the roundtable included the growing burden on frontline health workers, delays in disease detection, and the lack of scalable diagnostic infrastructure, particularly in underserved regions. Several speakers highlighted the urgent need to integrate AI-driven tools into India's healthcare framework, especially for early diagnosis of tuberculosis and non-communicable diseases. Shri Darshan Singh Chaudhary delivered a compelling statement in Hindi, calling AI "the need of the hour" for rural healthcare and urging greater focus on its implementation in resource-constrained areas. Though no formal partnerships were announced, the event generated substantial interest from Members of Parliament and senior officials to explore collaborative models with Attendees conveyed support for future pilots and initiatives, recognising the company's potential to deliver meaningful outcomes across public health programmes. "This roundtable was about action, not announcements," said Prashant Warier, CEO of "The presence of such diverse and respected voices shows that the ecosystem is ready to move from intent to impact. We're focused on real-world use cases, grounded policy support, and long-term commitment. Responsible AI is no longer optional; it has to be part of the foundation." recently named to the TIME100 Most Influential Companies list for 2025, is the only Indian company to feature in this year's edition. With over 4,500 deployments across more than 100 countries, including 1,200 sites in 25 Indian states, its AI solutions are used daily in real-world clinical settings, whether in rural mobile screening vans or high-volume emergency departments. The company's AI models, particularly those designed for chest X-ray interpretation, can detect conditions such as tuberculosis, lung nodules, lung cancer, heart failure and chronic obstructive pulmonary disease (COPD) within seconds. Qure's solutions have cleared findings and regulatory approvals in 92 chest X-ray AI solution has been evaluated by the World Health Organization (WHO) and included in its policy guidance for tuberculosis screening, including in settings without access to a human reader.. In addition to diagnostics, Qure's large language model-powered tools are helping healthcare providers generate structured reports and digitise medical records--critical functions for consistent and responsive care delivery. Qure's partnerships with AstraZeneca, Medtronic India, and Johnson & Johnson Medtech further demonstrate the platform's credibility and interoperability. These collaborations are not limited to product integration--they reflect the trust major Pharma and med-tech players place in Qure's technology and vision. With its latest Series D funding, is focused on deepening its presence in settings where the impact is immediate, from government-run primary health centres to tertiary hospitals. The company's solutions are designed to work within existing clinical workflows, ensuring that innovation complements rather than disrupts care delivery. The roundtable concluded on a strong note of alignment. Legislators, administrators, and public health experts echoed the belief that AI is not a futuristic add-on, but a present-day necessity to build more efficient, equitable, and scalable healthcare systems. The event has laid the groundwork for future collaborations, more policy engagement, and the continued recognition of as a quiet but essential partner in India's health innovation journey. About is a global health tech company that uses deep learning and Artificial Intelligence (AI) to make healthcare more accessible and equitable for patients worldwide. Qure's solutions power the efficient identification and management of Tuberculosis (TB), Lung Cancer and Neurocritical findings to support clinicians and propel developments in the pharmaceutical and medical device industries. The company empowers healthcare by helping to identify conditions fast, prioritize treatment planning and ultimately improve quality of patient life. has presence in over 100 countries, with regional offices in London and New York. The company is also part of the 2025 class of Time100 Most Influential Companies by Time Magazine. (ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same)
